0

As major home insurers flee storm-ravaged markets, Demotech’s ratings enable smaller ones to step in. A string of failures has left homeowners in the lurch.

0

The spread of electronic shelf labels to big U.S. retailers like Kroger and Walmart has raised questions about a future where prices could change in an instant.

0

The U.S. President gets his beloved 15% tariff but little else from Europe.

0

The pact imposes a baseline tariff of 15% on the U.S.’s biggest trading partner.

0

False records help Brazil’s dubious charge against a Bolsonaro ally.

0

Recognizing a state of Palestine before it exists does nothing for peace.

0

Who created a fake U.S. record of entry used to keep a Lula critic in Brazilian jail?

0

At NPR and PBS, bias has long been the biggest problem. Let 1,000 podcasts bloom.

0

A top FDA appointee who doesn’t think patients can be trusted to make their own healthcare decisions.

0

It used to be taboo to say you hated the Jews and wanted to wipe Israel off the map. Not anymore.

0

A stabbing suspect, who is believed to have acted alone, is in custody, but no motive is known, police say.

0

The Trump FDA tries to kill a therapy that has helped boys with a deadly diagnosis.

0

The Fed might have to raise the target rate to bring down inflation.

0

In 2000, there were 23 aluminum smelters in America. Now it’s down to four.

0

Consolidate your personal data with your passwords for convenience and security.

0

Expensive labels are trying to figure out why sales have weakened so much outside a recession.

0

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced better weight-loss results and fewer side effects.